Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Prestigious London Health Accelerator Accepts knus as Social Entrepreneurship School Participant

by
October 31, 2024
in Economy, Investing
0
Prestigious London Health Accelerator Accepts knus as Social Entrepreneurship School Participant
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

London, UK – knus, a leading health tech company, has been accepted into the prestigious School for Social Entrepreneurs (SSE) London Health Accelerator. This program, focused on supporting social enterprises addressing healthcare challenges and inequalities, will provide knus with valuable mentorship, industry expertise, and access to a powerful network to accelerate its mission of transforming mental health peer support through innovative digital solutions.

The SSE London Health Accelerator, in collaboration with MedCity and the UK Government’s UK Shared Prosperity Fund, is specifically designed for social enterprises working towards improving healthcare outcomes. The program’s unique curriculum is tailored to address the challenges of scaling social impact in the health sector, particularly in underserved communities.

Knus is a non-profit organization based in the UK that offers a free and confidential mental health peer support platform. The platform, designed to create a supportive community, connects service users with trained peer support coaches who have lived experiences with mental health challenges. Through this platform, individuals can discuss a variety of topics such as anxiety, depression, addiction, and bereavement in a safe online space. Volunteer coaches, guided by professionals such as doctors and social workers, offer resources and emotional support to users. Being accepted into the SSE London Health Accelerator is a significant achievement for knus as it aims to expand its reach and impact within the healthcare system.

Knus joins an impressive group of social entrepreneurs who share a commitment to addressing healthcare disparities and promoting community health. With the support of SSE London Health Accelerator, knus is looking forward to advancing its mission of making healthcare more accessible, informed, and equitable.

About knus (https://knus.io):

Knus is a pioneering health tech company dedicated to empowering service users and transforming mental healthcare delivery through digital innovation. By focusing on user-centric solutions, knus bridges the gap between technology and healthcare, enabling better-informed decisions and improving health outcomes.

About the School for Social Entrepreneurs (https://www.the-sse.org/):

The School for Social Entrepreneurs supports individuals from all backgrounds in tackling society’s biggest problems, with the vision of transforming lives and communities. Since 1997, the SSE has empowered over 2,500 social entrepreneurs and social impact organizations in the UK and beyond.

About MedCity (https://medcityhq.com):

MedCity is a life sciences cluster organization for London, fostering collaboration in the health, biotech, and medtech sectors to drive innovation, investment, and talent growth. Established by the Mayor of London, MedCity connects companies, researchers, and policymakers, supporting initiatives in drug discovery, medical devices, digital health, and data science. Its mission is to strengthen London’s position as a global science hub and improve health outcomes through partnerships and strategic support.

Distributed by Pressat (https://pressat.co.uk/):

This article has been distributed by Pressat, a leading press release distribution service based in the UK. Pressat helps organizations of all sizes gain media coverage and improve their online presence through effective and targeted distribution of press releases.

ShareTweetPin

Related Posts

NorthStar Gaming Announces Receipt of Management Cease Trade Order
Investing

NorthStar Gaming Announces Receipt of Management Cease Trade Order

May 9, 2025
US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025
Investing

US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025

May 9, 2025
Crypto Market Recap: New Hampshire Launches First State Crypto Reserve, Trump Stirs Controversy
Investing

Crypto Market Recap: New Hampshire Launches First State Crypto Reserve, Trump Stirs Controversy

May 8, 2025
SAGA Metals Extends Claims at the Radar Ti-V-Fe Project –Securing the Entire Titanomagnetite-Bearing Intrusion
Investing

SAGA Metals Extends Claims at the Radar Ti-V-Fe Project –Securing the Entire Titanomagnetite-Bearing Intrusion

May 8, 2025
5 Biggest Pharmaceutical ETFs in 2025
Investing

5 Biggest Pharmaceutical ETFs in 2025

May 7, 2025
Copper Crunch: China’s Stockpiles Depleting, US Demand Rising
Investing

Copper Crunch: China’s Stockpiles Depleting, US Demand Rising

May 7, 2025
Next Post
VPN for IoT: Securing Device Communications

VPN for IoT: Securing Device Communications

Recommended

Guo to reveal POGO mastermind in executive session

Guo to reveal POGO mastermind in executive session

September 24, 2024
“SocialBox.Biz: Leading the Charge for Sustainable Christmas 2024 through Long-Term Corporate Social Responsibility Solutions”

“SocialBox.Biz: Leading the Charge for Sustainable Christmas 2024 through Long-Term Corporate Social Responsibility Solutions”

December 2, 2024
Agencies’ incomplete documents delay PPP projects — NEDA chief

Agencies’ incomplete documents delay PPP projects — NEDA chief

September 12, 2024
“What is the perfect eyeglass frame size for a round face?”

“What is the perfect eyeglass frame size for a round face?”

September 18, 2024
The World of NBA Predictions

The World of NBA Predictions

October 14, 2024
Appellate court favors Ginebra in trademark lawsuit

Appellate court favors Ginebra in trademark lawsuit

January 1, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Terms & Conditions
    • Thank you

    Copyright © 2024 investdailypro.com | All Rights Reserved